Charles River Laboratories International, Inc. (CRL) by event type

CRL moves most on analyst upgrades — a median of -0.56% at 30 minutes across 55 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CRL overview →

By event type

How CRL reacts across 6 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
2,423 of 2,717
55-0.56%29%-0.53%
Analyst downgrades
508 of 2,603
41+0.38%63%+0.32%
Coverage initiations
1,549 of 2,283
17-0.13%29%+0.34%
Rating reiterations
1,450 of 3,522
94+0.02%51%+0.10%
Price-target raises
1,338 of 1,790
24-0.10%46%-0.26%
Price-target cuts
351 of 1,527
28+0.12%64%+0.66%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.

That’s how CRL usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · CRL overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
CATASYS (CATS)4340.00%41%
Cytocom Inc. (CBLI)4340.00%40%
Nymox Pharmaceutical Corporation (NYMX)4330.00%48%
IMMUNE DESIGN CORP COMMON STOCK (IMDZ)432-0.12%43%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.